The clinical trial results of a drug company can impact its stock price depending upon the outcome - and more so if it is a small-/mid-cap biopharma stock. A keen understanding of the target timeline of the clinical trials will help trade biotech stocks with some margin of safety around the catalyst events.
from RTT - Biotech https://ift.tt/2TKUncM
via IFTTT
No comments:
Post a Comment